Join us to see how we continue going beyond hemostasis testing
Join Siemens Healthineers at ISTH 2023 to:
Palais des Congrès de Montréal, Montréal, Canada
Accelerate hemostasis workflows and simplify testing
To help labs manage the complexity and increasing volumes of hemostasis testing, we continue to expand our portfolio with new technologies and ready-to-use assays to help streamline processes. Experience how our latest additions, Sysmex® CN Systems1 and the INNOVANCE® Anti-Xa assay,1 accelerate hemostasis workflows and simplify testing.
Sysmex CN-3000 and CN-6000 Systems1
Mid- and high-volume coagulation systems that combine fast, smart, and flexible testing in a small footprint.
Sysmex CS-5100 System
High-volume, fully automated solution featuring PSI® technology and automation connectivity.
Atellica COAG 360 System1
High-volume, automation-ready coagulation analyzer for specialty hemostasis labs.
Sysmex CS-2500 System
Mid-volume, fully automated solution featuring smartly designed technologies, including PSI checks.
INNOVANCE Anti-Xa assay1
An assay that simplifies anticoagulant testing, with a combined solution for heparin and DOAC testing.
Now available in the US:
INNOVANCE VWF Ac assay
A truly functional assay that sets a new standard in VWF activity determination.
Hemostasis and COVID-19
Assays for the detection and monitoring of coagulation disorders in COVID-19 patients.
Integrated platelet aggregation testing2
A solution that makes aggregation testing more manageable, reliable, and standardized.
Streamline operations, increase result accuracy, and reduce costs
Turbocharged by Atellica® Diagnostics IT, our scalable, configurable portfolio of lab automation solutions supports varying needs, space, and discipline-specific requirements to enhance workflows in labs of all sizes.
A broad portfolio of scalable and customizable automation solutions to streamline multidisciplinary workflows in labs of all sizes.
Atellica Diagnostics IT solutions
Scalable, easy-to-use solutions to simplify tasks and maximize the effectiveness of your laboratory and its staff.
Turn IVDR transition challenges into opportunities
To continue providing our solutions in the future, we've taken all the necessary steps to ensure compliance with the new In Vitro Diagnostics Regulation (IDVR). As a leader in hemostasis, and with the experience we have gained, we can provide support that goes beyond testing - sharing insights and best practices to support you in the successful implementation of IVDR.
Watch recordings of our ISTH presentation theater sessions on IVDR implementation on PEPconnect
Dr. Sanja Matern: Regulatory Basics and Manufacturer's Perspective
Prof. Dr. Ulrich Sachs: Practical Laboratory Experience
Watch our presentation theater on-demand: Managing the Challenges of IVDR Transition Together
Join Prof. Dr. Ulrich Sachs, Head of the Department of Thrombosis and Hemostasis at the Giessen and Marburg University Hospital, Giessen, Germany and IVDR expert Dr. Sanja Matern, Manager of Regulatory Affairs, Siemens Healthineers, Germany, as they share insights on the changing regulatory requirements and their experiences with lab implementation.
The products/features/applications mentioned here are not commercially available in all countries and are subject to local regulations. Their future availability cannot be guaranteed. Not available for sale in the U.S.
The products/features are not commercially available in all countries. Due to regulatory reasons, their future availability cannot be guaranteed. Please contact your local Siemens Healthineers organization for further details. In the U.S., platelet aggregation testing is for research use only, not for use in diagnostic procedures.
vWF Ag assay is under review by the FDA. A clearance is pending and the product is not yet commercially available in the United States. Product availability may vary from country to country and is subject to varying regulatory requirements.
Atellica, INNOVANCE, PSI, and all associated marks are trademarks of Siemens Healthcare Diagnostics Inc., or its affiliates. Sysmex is a trademark of Sysmex Corporation. All other trademarks and brands are the property of their respective owners.
Sysmex CN-3000 and Sysmex CN-6000 Systems refer to Automated Blood Coagulation Analyzer CN-3000 and Automated Blood Coagulation Analyzer CN-6000 respectively. Sysmex CS-2500 System, CS-5100 System refer to Automated Blood Coagulation Analyzer CS-2500 and Automated Blood Coagulation Analyzer CS-5100 respectively. Sysmex CN Systems or Sysmex CN-3000 and CN-6000 Systems refers to Automated Blood Coagulation Analyzer CN-3000 and Automated Blood Coagulation Analyzer CN-6000. Sysmex CS Systems refers to Automated Blood Coagulation Analyzer CS-5100 and Automated Blood Coagulation Analyzer CS-2500.
Product availability may vary from country to country and is subject to varying regulatory requirements. Please contact your local representative for availability.